Penis (excludes Malignant Melanoma, Merkel Cell Carcinoma, Kaposi Sarcoma, Mycosis Fungoides, Sezary Disease and Other Lymphomas)
Primary Site | Histology | Staging Type |
---|---|---|
C600-C602, C608-C609 | 8000-8246, 8248-8576, 8940-8950, 8980-8981 | TNM 7 and Summary Stage |
C600-C602, C608-C609 | 8577-8713, 8800-8939, 8951-8979, 8982-9136, 9141-9582 | Summary Stage only |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
C600 Prepuce C601 Glans penis C602 Body of penis C608 Overlapping lesion of penis C609 Penis, NOS **Note 1:** This schema is based on the UICC chapter *Penis* pages 239-242. * Primary sites C608 and C609 are listed in the chapter heading but are not specified in the anatomic subsites in this chapter of the UICC manual; however, they are included in this schema and TNM staged if appropriate histology criteria are met * This schema is NOT used for Malignant Melanoma, Merkel Cell Carcinoma of Penis, Kaposi Sarcoma, Mycosis Fungoides, Sezary Disease, or other Lymphomas. Each of these diseases has a separate schema **Note 2:** Primary carcinoma of the urethra is to be coded C680 and coded in the Urethra schema. **Note 3:** In addition to directly assigning TNM, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Penis (including Skin of Penis* chapter on page 228 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=228).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | Yes | NAACCR #940 | None | |
Clinical N | <BLANK> | Yes | NAACCR #950 | None | |
Clinical M | <BLANK> | Yes | NAACCR #960 | None | |
TNM Clin Stage Group | 99 | Yes | NAACCR #970 | None | |
Pathologic T | <BLANK> | Yes | NAACCR #880 | None | |
Pathologic N | <BLANK> | Yes | NAACCR #890 | None | |
Pathologic M | <BLANK> | Yes | NAACCR #900 | None | |
TNM Path Stage Group | 99 | Yes | NAACCR #910 | None | |
SSF10: Involvement of Corpus Spongiosum/Corpus Cavernosum | 999 | No | NAACCR #2864 | CCCR/Canada COC SEER |
None |
SSF11: Poorly Differentiated Tumor Percentage | 988 | No | NAACCR #2865 | None | None |
SSF12: Human Papilloma Virus (HPV) Status | 988 | No | NAACCR #2866 | None | None |
SSF16: Size of Metastasis in Lymph Nodes | 988 | No | NAACCR #2870 | None | None |
SSF17: Extranodal Extension of Regional Lymph Nodes | 999 | No | NAACCR #2871 | CCCR/Canada SEER |
None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No | NAACCR #390 | None | |
Primary Site | <BLANK> | Yes | NAACCR #400 | None | |
Histology | <BLANK> | Yes | NAACCR #522 | None | |
Behavior | <BLANK> | Yes | NAACCR #523 | None | |
RX Summ Systemic/Surgery Sequence | <BLANK> | Yes | NAACCR #1639 | None | |
RX Summ Surgery/Radiation Sequence | <BLANK> | Yes | NAACCR #1380 | None | |
Regional Nodes Positive | <BLANK> | Yes | NAACCR #820 | None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | 1.1 | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
None |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
None |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
None |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
None |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
None |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
None |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
None |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
None |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
None |
None |